Pain is a sensory experience that is subjective and an individual experience. Labour pain if not adequately controlled can lead to maternal and fetal sequelae because of widespread maternal sympathetic activation that causes increase in cardiac output, blood pressure and pulse rate of the mother. Providing effective and safe analgesia during labour has remained an ongoing challenge. A good analgesic will provide safe and effective analgesia in labour with minimal maternal and fetal side effects. Patients satisfying the inclusion /exclusion criteria, 35 in each arm, were taken into the study after taking informed consent. All patients were interviewed with a structured questionnaire to elicit presenting complaints, obstetric history, past medical and surgical history. The first participant included in the study group was selected randomly and thereafter alternate participants were included in the interventional group. In the intervention group, the mean VAS score before the drug administration, in the first stage of labour was 7.54 with a standard deviation (SD) of 1.597, while in the control group the mean Vas score was 6.58 with SD of 0.998.In the intervention group, the mean VAS score after the drug administration in the first stage of labour was 3.76 with SD of 1.611, while in the control group the mean Vas score remained at 6.58 with SD of 0.998. The student t test was used to compare the data across the groups, t=8.739, and p=.000, p-value <0.001 → is found to be statistically significant.